Peter Wehrwein
Articles
Semaglutide Cuts Cardiovascular Risk by 20% in Adults with Obesity, CVD and Without Diabetes
November 13th 2023AHA 2023: Semaglutide 2.4 mg reduced the risk of serious cardiovascular events by 20% in patients with obesity and overweight with established CVD but without diabetes, according to full SELECT trialresults.
Latest Updated Articles
Published: January 29th 2014 | Updated: December 24th 2024
What's This "Red Spot"?
Published: April 11th 2014 | Updated: December 24th 2024
What Cause of This Itchy Rash?
Published: December 21st 2024 | Updated: December 24th 2024
Impact of Delayed Intervention in Stage 2 Type 1 Diabetes
Published: December 21st 2024 | Updated: December 24th 2024
Living with Type 1 Diabetes
Published: December 21st 2024 | Updated: December 24th 2024
Stages and Symptoms of Type 1 Diabetes
Published: December 21st 2024 | Updated: December 24th 2024
Screening Guidelines for Type 1 Diabetes
